<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="t2-ijn-9-5603" position="float">
 <label>Table 2</label>
 <caption>
  <p>Summary of cattle treatments</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th valign="top" align="left" rowspan="1" colspan="1">Group</th>
    <th valign="top" align="left" rowspan="1" colspan="1">Treatment</th>
    <th valign="top" align="left" rowspan="1" colspan="1">Animal number</th>
    <th valign="top" align="left" rowspan="1" colspan="1">Route of administration</th>
    <th valign="top" align="left" rowspan="1" colspan="1">Each dose</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Gr-1
     <break/>Inactivated vaccine
     <break/>(IM)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">FMD inactivated vaccine</td>
    <td valign="top" align="left" rowspan="1" colspan="1">5</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Intramuscular route
     <break/>10 days previously (-11 dpv)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">0.2 mL
     <break/>(6–7.5 μg, 146s)
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Gr-2
     <break/>Chi-Tre-Inactivated
     <break/>(3×IN)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Chi-Tre-Inactivated nanoparticles</td>
    <td valign="top" align="left" rowspan="1" colspan="1">5</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Intranasal route
     <break/>3 times on days 1, 4, 7
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">150 mg
     <break/>(10–15 μg, 146s)
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Gr-3
     <break/>Chi-Tre-Inactivated
     <break/>(1×IN)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Chi-Tre-Inactivated nanoparticles</td>
    <td valign="top" align="left" rowspan="1" colspan="1">5</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Intranasal route
     <break/>A double dose for 1 time
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">300 mg
     <break/>(25–30 μg, 146s)
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Gr-4
     <break/>Chi-PLGA-DNA
     <break/>(3×IN)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Chi-PLGA-DNA nanoparticles</td>
    <td valign="top" align="left" rowspan="1" colspan="1">5</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Intranasal route
     <break/>3 times on days 1, 4, 7
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">150 mg
     <break/>(1–1.3 mg, vector)
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Gr-5
     <break/>Chi-Tre-PLGA
     <break/>(3×IN)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Chi-PLGA and trehalose nanoparticles</td>
    <td valign="top" align="left" rowspan="1" colspan="1">3</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Intranasal route
     <break/>3 times on days 1, 4, 7
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">150 mg
     <break/>Negative control
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="tfn2-ijn-9-5603">
   <p>
    <bold>Notes:</bold> At 10 days postvaccination, animals were housed in two pens and challenged for 48 hours by direct contact with two infected donor cattle per pen. The donors were inoculated intradermally, at two sites on the upper surface of the tongue with 0.2 mL of cattle-passaged FMDV AF/72, at 48 hours before challenge. After challenge, the donors were separated and killed, and unvaccinated cattle were removed and housed separately. The 24 vaccinated cattle were monitored daily for clinical signs of FMD after contact challenge. Signs included occurrence of vesicles, lameness, increased salivation, and fever (rectal temperature &gt;39.5°C). Cohabitation for more than 48 hours was adopted following preliminary experiments on direct-contact challenge in cattle in our laboratory.
   </p>
  </fn>
  <fn id="tfn3-ijn-9-5603">
   <p>
    <bold>Abbreviations:</bold> 1×IN, one time by intranasal route; 3×IN, three times by intranasal route; Chi-PLGA-DNA, chitosan-coated PLGA nanoparticles loaded with plasmid DNA nanoparticles; Chi-Tre-Inactivated, chitosan-trehalose-inactivated FMDV nanoparticles; dpv, days postvaccination; FMD, foot-and-mouth disease; FMDV, foot-and-mouth disease virus; IM, intramuscular; PLGA, poly(lactic-co-glycolic acid).
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
